Menu
GeneBe

chr3-42513831-C-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_004624.4(VIPR1):​c.161C>A​(p.Ala54Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00243 in 1,551,556 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0025 ( 6 hom. )

Consequence

VIPR1
NM_004624.4 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.722
Variant links:
Genes affected
VIPR1 (HGNC:12694): (vasoactive intestinal peptide receptor 1) This gene encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Vasoactive intestinal peptide is involved in smooth muscle relaxation, exocrine and endocrine secretion, and water and ion flux in lung and intestinal epithelia. Its actions are effected through integral membrane receptors associated with a guanine nucleotide binding protein which activates adenylate cyclase. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
VIPR1-AS1 (HGNC:40610): (VIPR1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005968094).
BS2
High Homozygotes in GnomAdExome4 at 6 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
VIPR1NM_004624.4 linkuse as main transcriptc.161C>A p.Ala54Asp missense_variant 2/13 ENST00000325123.5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
VIPR1ENST00000325123.5 linkuse as main transcriptc.161C>A p.Ala54Asp missense_variant 2/131 NM_004624.4 P4P32241-1
VIPR1-AS1ENST00000452639.7 linkuse as main transcriptn.1008-1539G>T intron_variant, non_coding_transcript_variant 5

Frequencies

GnomAD3 genomes
AF:
0.00139
AC:
211
AN:
152150
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00278
Gnomad OTH
AF:
0.000955
GnomAD3 exomes
AF:
0.00118
AC:
185
AN:
156354
Hom.:
1
AF XY:
0.00106
AC XY:
87
AN XY:
82244
show subpopulations
Gnomad AFR exome
AF:
0.000114
Gnomad AMR exome
AF:
0.000121
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000390
Gnomad NFE exome
AF:
0.00283
Gnomad OTH exome
AF:
0.000908
GnomAD4 exome
AF:
0.00254
AC:
3554
AN:
1399288
Hom.:
6
Cov.:
30
AF XY:
0.00236
AC XY:
1629
AN XY:
690184
show subpopulations
Gnomad4 AFR exome
AF:
0.000190
Gnomad4 AMR exome
AF:
0.000168
Gnomad4 ASJ exome
AF:
0.0000795
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000252
Gnomad4 FIN exome
AF:
0.000609
Gnomad4 NFE exome
AF:
0.00315
Gnomad4 OTH exome
AF:
0.00185
GnomAD4 genome
AF:
0.00139
AC:
211
AN:
152268
Hom.:
1
Cov.:
32
AF XY:
0.00129
AC XY:
96
AN XY:
74442
show subpopulations
Gnomad4 AFR
AF:
0.000289
Gnomad4 AMR
AF:
0.000261
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000377
Gnomad4 NFE
AF:
0.00278
Gnomad4 OTH
AF:
0.000945
Alfa
AF:
0.00244
Hom.:
0
Bravo
AF:
0.00153
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000484
AC:
2
ESP6500EA
AF:
0.00213
AC:
17
ExAC
AF:
0.000624
AC:
42

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 06, 2021The c.161C>A (p.A54D) alteration is located in exon 2 (coding exon 2) of the VIPR1 gene. This alteration results from a C to A substitution at nucleotide position 161, causing the alanine (A) at amino acid position 54 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
12
DANN
Uncertain
0.98
Eigen
Benign
-0.53
Eigen_PC
Benign
-0.47
FATHMM_MKL
Benign
0.061
N
LIST_S2
Benign
0.45
T;T;T;T
M_CAP
Benign
0.0093
T
MetaRNN
Benign
0.0060
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
1.0
D;D;N;N
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.2
N;N;N;N
REVEL
Benign
0.13
Sift
Benign
0.22
T;T;T;T
Sift4G
Benign
0.63
T;D;D;T
Polyphen
0.54
.;.;.;P
Vest4
0.20
MVP
0.42
MPC
0.13
ClinPred
0.010
T
GERP RS
2.3
Varity_R
0.11
gMVP
0.75

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs140984283; hg19: chr3-42555323; COSMIC: COSV57296768; COSMIC: COSV57296768; API